Literature DB >> 223248

Experimental studies on the mechanism of action of timolol.

A H Neufeld.   

Abstract

Timolol, which binds to beta-adrenergic receptors, is a potent antagonist of the catecholamine-stimulated synthesis of cyclic AMP. However, the actual mechanism of action by which timolol reduces intraocular pressure is not readily apparent. Compared to its efficacy in human eyes, the drug is relatively ineffective in rabbit eyes. A reasonable postulate is that soon after administration, timolol blocks endogenous adrenergic stimulation contributing to the formation of aqueous humor by the ciliary processes. Nevertheless, the long-lasting reduction of intraocular pressure persists at a time when the drug is no longer bound to beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223248     DOI: 10.1016/0039-6257(79)90229-7

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  12 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  Is topical haloperidol a useful glaucoma treatment?

Authors:  M J Lavin; V Andrews
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

3.  Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressure.

Authors:  J A Nathanson
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

4.  Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium.

Authors:  J A Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

5.  Beta adrenergic receptors in pigmented ciliary processes.

Authors:  G E Trope; B Clark
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

6.  [The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].

Authors:  M Ober; A Scharrer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

Review 7.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

8.  VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans.

Authors:  Keiko Fujikawa; Takeshi Iwata; Kaoru Inoue; Masakazu Akahori; Hanako Kadotani; Masahiro Fukaya; Masahiko Watanabe; Qing Chang; Edward M Barnett; Wojciech Swat
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

9.  Vasoconstrictive effect of topical timolol on human retinal arteries.

Authors:  X D Martin; P A Rabineau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

10.  Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.

Authors:  J V Thomas; D L Epstein
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.